Fate Therapeutics Email Formats
Biotechnology Research • 
San Diego, California, United States • 201-500 Employees
Fate Therapeutics Email Formats
Fate Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@fatetherapeutics.com), used 73% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@fatetherapeutics.com | 73% |
{first name}.{last name} | john.doe@fatetherapeutics.com | 25.2% |
Key Contacts at Fate Therapeutics
Gabriela Velasquez
Senior Director, Talent Management
Graham Hirst
Senior Director, Facilities, Eh&S And Security
Karina Palomares
Director, Process Development
Bhaskar Thyagarajan
Senior Director, Program Management
Scott Breier
Associate Director, Facilities Operations & Engineering
Sahar Roshan
Director Clinical Operations
John Goulding
Director Of Research Development
Tingxia Guo
Director, Supply Chain Management And External Manufacturing
Jode Goodridge
Executive Director
Kathy Schearing
Sr. Director, Clinical Outsourcing, Monitoring & Process Improvement
Company overview
| Headquarters | 12278 Scripps Summit Dr, San Diego, California 92131, US |
| Phone number | +18588751800 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Stem Cells, Cell Therapy, Immuno-Oncology, Ipscs, Ips Cells, Stem Cell Modulators, T Cells, Pluripotent Stem Cells, Nk Cells, Autoimmune Disorders, Car T, Off-The-Shelf |
| Founded | 2007 |
| Employees | 201-500 |
| Socials |
About Fate Therapeutics
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s effector cell pipeline includes multiplexed-engineered, iPSC-derived natural killer (NK) cell and T-cell product candidates, which incorporate novel synthetic controls of cell function, such as chimeric antigen receptors (CARs) to target tumor-associated antigens and are intended to deliver multiple mechanisms of therapeutic importance to patients including in combination with well-established cancer therapies. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Fate Therapeutics has 95 employees across 14 departments.
Departments
Number of employees
Funding Data
Explore Fate Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Fate Therapeutics Tech Stack
Discover the technologies and tools that power Fate Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Cookie compliance
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Webmail
Programming languages
Security
Blogs
Analytics
Netherlands
Myanmar
CanadaFrequently asked questions
4.8
40,000 users
